Loading...
OTCM
MDMXF
Market cap508mUSD
, Last price  
USD
Name

medmix AG

Chart & performance

D1W1MN
OTCM:MDMXF chart
P/E
—
P/S
—
EPS
0.16
Vol. 1Y
—
Shs. 5Y
0.12%
Rev. 5Y
4.98%
Div Yld LY
—
Div Yld TTM
—
Revenues
448m
-7.42%
454,000,000420,700,000351,300,000457,300,000477,100,000486,600,000483,900,000448,000,000
Net income
6m
P
52,200,00025,200,0009,600,00044,000,00011,600,000300,000-7,400,0006,400,000
CFO
68m
-21.71%
94,200,00089,100,00050,600,00087,300,00047,600,00056,100,00086,600,00067,800,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1922 and headquartered in Zug, Switzerland, Medmix AG stands as a global leader in innovating, manufacturing, and distributing high-precision devices and services. These solutions are meticulously engineered for the controlled mixing, application, and injection of liquids across various viscosities, serving diverse healthcare, consumer, and industrial markets worldwide. The company operates through five key divisions: Dental, Drug Delivery, Surgery, Industry, and Beauty. The Dental segment offers essential tools such as mixing tips, dispensers, needles, and accessories, alongside support services for applications including prosthetics, restorative procedures, anesthesiology, and cosmetic dentistry. In its Drug Delivery segment, Medmix develops critical devices for administering medications like fertility drugs, growth hormones, and treatments for specific diabetes conditions, osteoporosis, and rare diseases. The Surgery segment provides specialized mixing and delivery systems utilized for injecting bone cement and applying hemostatic sealants to manage both internal and external wounds during surgical interventions. For industrial clients, the Industry division produces robust dispensers, cartridges, and mixers for two-component adhesives and sealants, indispensable in sectors such as construction, transportation, electronics, infrastructure, and broader manufacturing. Lastly, the Beauty segment supplies micro brushes, mascara applicators, lip gloss, and concealers. Medmix AG markets its comprehensive product range under well-recognized brands, including Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka.

Key people

Rob Ten Hoedt
Non-Executive Chairman of the Board · since 2023
Independent Chairman of the Board · since 2021
Rene Willi
Chief Executive Officer, Member of the Executive Committee · since 2024
Marco Musetti
Independent Vice Chairman of the Board
Chief Financial Officer, Member of the Executive Committee · since 2021
Itee Satpathy
Chief Human Resources, Sustainability Officer, Member of the Executive Committee · since 2024
Xavier Schops
Chief Legal Officer, Company Secretary, Head of Corporate Affairs, Member of the Executive Committee · since 2023
Barbara Angehrn
Member of the Board of Director · since 2022
Daniel Flammer
Member of the Board of Director · since 2022
Susanne Hundsbaek-Pedersen
Member of the Board of Director · since 2024
David Metzger
Member of the Board of Director · since 2022
IPO date
Sep 30, 2021
Employees
2,245
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT